Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 167218)

Published in J Virol on August 01, 2003

Authors

Bettina-Judith Höhlich1, Karl-Heinz Wiesmüller, Tobias Schlapp, Bernd Haas, Eberhard Pfaff, Armin Saalmüller

Author Affiliations

1: Institut für Immunologie, Bundesforschungsanstalt für Viruskrankheiten der Tiere, 72076 Tübingen, Germany.

Articles citing this

A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol (2012) 0.99

Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J Virol (2009) 0.82

An overview on ELISA techniques for FMD. Virol J (2011) 0.80

Development of a blocking ELISA based on a monoclonal antibody against a predominant epitope in non-structural protein 3B2 of foot-and-mouth disease virus for differentiating infected from vaccinated animals. PLoS One (2014) 0.79

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1. Adv Appl Bioinform Chem (2013) 0.79

Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B. J Clin Microbiol (2015) 0.78

Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus. Clin Vaccine Immunol (2015) 0.77

Development and validation of a prokaryotically expressed foot-and-mouth disease virus non-structural protein 2C'3AB-based immunochromatographic strip to differentiate between infected and vaccinated animals. Virol J (2011) 0.77

Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection. Virol J (2014) 0.77

Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine. PLoS One (2017) 0.75

Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens. Clin Diagn Lab Immunol (2005) 0.75

Articles cited by this

Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res (1984) 3.81

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J (1982) 3.32

A third antigenic component associated with foot-and-mouth disease infection. Virology (1966) 1.67

Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61

A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J Immunol Methods (1986) 1.52

Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol (1998) 1.34

Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol (1988) 1.32

The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol (1997) 1.27

A new sensitive serological assay for detection of lentivirus infections in small ruminants. Clin Diagn Lab Immunol (1999) 1.12

Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine. J Hyg (Lond) (1979) 1.12

Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci (1995) 1.10

Expression of the aphthovirus RNA polymerase gene in Escherichia coli and its use together with other bioengineered nonstructural antigens in detection of late persistent infections. Virology (1991) 1.03

Evidence for an internal antigen in foot-and-mouth disease virus. J Gen Virol (1969) 1.02

Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol (1994) 0.95

Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch Virol (1997) 0.95

Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. J Virol Methods (1997) 0.89

Antibody responses to type-specific and "virus-infection-associated" antigens in cattle vaccinated with inactivated polyvalent foot and mouth disease virus in North Malawi. Br Vet J (1978) 0.88

Function of minor polypeptides in foot-and-mouth disease virus and poliovirus. Trends Microbiol (1994) 0.83

Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Vet Q (1998) 0.83

Articles by these authors

Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol (2005) 1.84

Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol (2007) 1.81

TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem (2006) 1.80

Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol (2004) 1.74

Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med (2014) 1.57

Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc Natl Acad Sci U S A (2008) 1.43

Porcine T lymphocytes and NK cells--an update. Dev Comp Immunol (2008) 1.39

A portable reverse transcription recombinase polymerase amplification assay for rapid detection of foot-and-mouth disease virus. PLoS One (2013) 1.37

Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine (2008) 1.36

Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol (2003) 1.35

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol Med (2012) 1.29

Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J (2005) 1.28

The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine (2007) 1.26

Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol (2005) 1.22

Quantitative detection of Chlamydia psittaci and C. pecorum by high-sensitivity real-time PCR reveals high prevalence of vaginal infection in cattle. J Clin Microbiol (2003) 1.21

The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc Natl Acad Sci U S A (2002) 1.13

Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma. Leuk Res (2010) 1.10

Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol (2005) 1.08

Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine. Virus Res (2006) 1.06

Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS One (2008) 1.03

Phenotypic maturation of porcine NK- and T-cell subsets. Dev Comp Immunol (2013) 1.02

Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships. Vaccine (2004) 1.01

Bidirectional binding of invariant chain peptides to an MHC class II molecule. Proc Natl Acad Sci U S A (2010) 0.99

Identification of a calicivirus isolate of unknown origin. J Gen Virol (2003) 0.99

Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J Gen Virol (2002) 0.99

Phenotypic and functional characterisation of porcine CD4(+)CD25(high) regulatory T cells. Vet Immunol Immunopathol (2007) 0.96

The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation. PLoS Pathog (2010) 0.96

In situ assembly of macromolecular complexes triggered by light. Proc Natl Acad Sci U S A (2010) 0.96

Porcine SWC1 is CD52--final determination by the use of a retroviral cDNA expression library. Vet Immunol Immunopathol (2012) 0.96

Detection of Foxp3 protein expression in porcine T lymphocytes. Vet Immunol Immunopathol (2008) 0.95

A CD14 domain with lipopolysaccharide-binding and -neutralizing activity. Chembiochem (2006) 0.95

Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J Gen Virol (2003) 0.95

Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells. Vet Immunol Immunopathol (2007) 0.94

Porcine CD27: identification, expression and functional aspects in lymphocyte subsets in swine. Dev Comp Immunol (2012) 0.93

Coexistence of group I and group II chaperonins in the archaeon Methanosarcina mazei. J Biol Chem (2003) 0.93

Characterization of immunostimulatory components of orf virus (parapoxvirus ovis). J Gen Virol (2011) 0.92

Identification of a novel foot-and-mouth disease virus specific T-cell epitope with immunodominant characteristics in cattle with MHC serotype A31. Vet Res (2007) 0.92

Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Rev Vaccines (2010) 0.91

NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity. J Immunol (2013) 0.91

Characterization of structural features controlling the receptiveness of empty class II MHC molecules. PLoS One (2011) 0.90

Physicochemical and biological analysis of synthetic bacterial lipopeptides: validity of the concept of endotoxic conformation. J Biol Chem (2007) 0.89

Porcine T-helper and regulatory T cells exhibit versatile mRNA expression capabilities for cytokines and co-stimulatory molecules. Cytokine (2012) 0.88

Conformation of peptides bound to the transporter associated with antigen processing (TAP). Proc Natl Acad Sci U S A (2011) 0.88

Detection of intracellular antigens in porcine PBMC by flow cytometry: A comparison of fixation and permeabilisation reagents. Vet Immunol Immunopathol (2007) 0.88

DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther (2005) 0.87

NKp46 expression discriminates porcine NK cells with different functional properties. Eur J Immunol (2012) 0.87

Porcine regulatory T cells: mechanisms and T-cell targets of suppression. Dev Comp Immunol (2011) 0.86

A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens. J Immunol Methods (2010) 0.86

High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. J Immunol (2002) 0.86

Longitudinal prevalence study of diarrheagenic Escherichia coli in dairy calves. Berl Munch Tierarztl Wochenschr (2007) 0.86

Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model. PLoS One (2012) 0.86

Detection of quantitative trait loci for resistance/susceptibility to pseudorabies virus in swine. J Gen Virol (2002) 0.85

Reinfection with Chlamydophila abortus by uterine and indirect cohort routes reduces fertility in cattle preexposed to Chlamydophila. Infect Immun (2004) 0.85

Regulators of G-protein signalling are modulated by bacterial lipopeptides and lipopolysaccharide. FEBS J (2008) 0.85

Porcine CD8αdim/-NKp46high NK cells are in a highly activated state. Vet Res (2013) 0.84

Biosynthesis of Wdr16, a marker protein for kinocilia-bearing cells, starts at the time of kinocilia formation in rat, and wdr16 gene knockdown causes hydrocephalus in zebrafish. J Neurochem (2007) 0.84

Generation of inducible hepatitis C virus transgenic mouse lines. J Med Virol (2007) 0.84

Inhibition of prion amplification by expression of dominant inhibitory mutants--a systematic insertion mutagenesis study. Infect Disord Drug Targets (2009) 0.84

Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int (2002) 0.84

Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine (2007) 0.83

Reducing animal experimentation in foot-and-mouth disease vaccine potency tests. Vaccine (2011) 0.83

Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer. Vet Res (2010) 0.83

CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes. Bioconjug Chem (2011) 0.83

Experimental infection of wild boar and domestic pigs with a foot and mouth disease virus strain detected in the southeast of Bulgaria in December of 2010. Vet Microbiol (2012) 0.83

Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination. Vet Res (2005) 0.83

Reduced proteinase K resistance and infectivity of prions after pressure treatment at 60 degrees C. J Gen Virol (2004) 0.82

Sensitive detection of Foxp3 expression in bovine lymphocytes by flow cytometry. Vet Immunol Immunopathol (2010) 0.82

Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships. J Med Chem (2006) 0.82

Mimotope vaccines for cancer immunotherapy. Vaccine (2007) 0.82

Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J Virol (2009) 0.82

Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells. Cancer Immunol Immunother (2010) 0.81

Fowl adenovirus (FAdV) serotype 4 causes depletion of B and T cells in lymphoid organs in specific pathogen-free chickens following experimental infection. Vet Immunol Immunopathol (2007) 0.81

CD27 expression discriminates porcine T helper cells with functionally distinct properties. Vet Res (2013) 0.81

Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes. J Gen Virol (2003) 0.81

Effect of radiation on vascular endothelial growth factor expression in the C2 canine mastocytoma cell line. Am J Vet Res (2009) 0.81

Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin. Anaerobe (2005) 0.81

Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope. Eur J Immunol (2003) 0.81

Interferon-gamma response of PBMC indicates productive pseudorabies virus (PRV) infection in swine. Vet Immunol Immunopathol (2004) 0.80

A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives. Antimicrob Agents Chemother (2011) 0.80

Selectivity of competitive multivalent interactions at interfaces. Chembiochem (2009) 0.80

Lipid-labeling facilitates a novel magnetic isolation procedure to characterize pathogen-containing phagosomes. Traffic (2012) 0.79

Current knowledge on porcine regulatory T cells. Vet Immunol Immunopathol (2011) 0.79

Silica-based monoliths for rapid peptide screening by capillary liquid chromatography hyphenated with electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom (2003) 0.79

Bioinformatics for mass spectrometry-based metabolomics. Methods Mol Biol (2011) 0.79

The activity of lipopeptide TLR2 agonists critically depends on the presence of solubilizers. Eur J Immunol (2007) 0.79